title: Pulmonary Practice Pearls for Primary Care Physicians 13-part eNewsletter series.
abstract: The aim of this supplement is to provide an introduction to recent advances in the understanding of the impact of microorganisms on the normal and diseased lung for patients with asthma and COPD.
authors: Director of Research, Olmsted Medical Center, Rochester, MN, USA.
authors: Barbara P
authors: BP
authors: Yawn
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001249:Asthma / Q000382:microbiology* / Q000628:therapy*; D017963:Azithromycin / Q000627:therapeutic use*; D018893:Bronchoalveolar Lavage; D018450:Disease Progression; D019317:Evidence-Based Medicine; D005938:Glucocorticoids / Q000627:therapeutic use; D006190:Haemophilus / Q000302:isolation & purification; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000379:methods; D008297:Male; D064307:Microbiota / Q000187:drug effects / Q000276:immunology; D008875:Middle Aged; D009016:Moraxella / Q000302:isolation & purification; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009330:Nebulizers and Vaporizers; D009346:Neisseriaceae / Q000302:isolation & purification; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods / Q000592:standards / Q000639:trends; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D018727:Muscarinic Antagonists; D017963:Azithromycin